Seven Distinct Patterns of Substance Use Found Among Pregnant Women in the U.S.
Among 15,429 postpartum women, latent class analysis identified seven substance use patterns including a distinct pre-pregnancy cannabis user class (5.5%) who largely stopped during pregnancy.
Quick Facts
What This Study Found
Seven latent classes of maternal substance use were identified: minimal users (70.7%), pre-pregnancy cigarette users (10.5%), persistent cigarette users (6.8%), pre-pregnancy cannabis users (5.5%), broad polysubstance users (3.6%), opioid-only users (1.9%), and persistent cigarette/opioid co-users (1.0%). Groups differed significantly by age, income, race/ethnicity, and pre-pregnancy alcohol use.
Key Numbers
15,429 participants representing 384,918 births. 51.3% aged 20-29. 73.3% non-Hispanic White. Seven classes: minimal (70.7%), pre-pregnancy cigarettes (10.5%), persistent cigarettes (6.8%), pre-pregnancy cannabis (5.5%), broad polysubstance (3.6%), opioid-only (1.9%), persistent cigarette+opioid (1.0%).
How They Did This
Analysis of 15,429 PRAMS postpartum survey participants (2016-2018) from seven U.S. states, representing 384,918 live singleton births. Latent class analysis identified patterns of substance use before and during pregnancy. State-level survey weights applied.
Why This Research Matters
Identifying distinct substance use patterns rather than treating all prenatal substance exposure as equivalent can help target interventions more effectively and understand different risk profiles for perinatal outcomes.
The Bigger Picture
The pre-pregnancy cannabis user class (5.5%) is notable because these women largely stopped cannabis use during pregnancy, distinguishing them from persistent substance users. This suggests cannabis-using women may be responsive to pregnancy-motivated cessation.
What This Study Doesn't Tell Us
Self-reported substance use likely underestimates prevalence. Only seven states included, limiting national representativeness. Cannot determine substance quantities or frequency within classes. 73.3% non-Hispanic White limits racial/ethnic diversity.
Questions This Raises
- ?Do the perinatal outcomes differ across these seven substance use classes?
- ?What motivates pre-pregnancy cannabis users to stop during pregnancy while cigarette users persist?
Trust & Context
- Key Stat:
- 5.5% of postpartum women fell in a distinct pre-pregnancy cannabis user class who largely stopped during pregnancy
- Evidence Grade:
- Large representative sample with sophisticated latent class methodology, but self-report and limited state coverage reduce precision.
- Study Age:
- 2025 publication with 2016-2018 PRAMS data.
- Original Title:
- Typologies of Maternal Substance Use in Pregnancy: Latent Classes and Sociodemographic Correlates in a U.S. Sample.
- Published In:
- Journal of studies on alcohol and drugs, 86(5), 694-702 (2025)
- Database ID:
- RTHC-06748
Evidence Hierarchy
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-06748APA
Jenkins, Marina C; Ehrenthal, Deborah B; Bautista, Leonelo E. (2025). Typologies of Maternal Substance Use in Pregnancy: Latent Classes and Sociodemographic Correlates in a U.S. Sample.. Journal of studies on alcohol and drugs, 86(5), 694-702. https://doi.org/10.15288/jsad.24-00210
MLA
Jenkins, Marina C, et al. "Typologies of Maternal Substance Use in Pregnancy: Latent Classes and Sociodemographic Correlates in a U.S. Sample.." Journal of studies on alcohol and drugs, 2025. https://doi.org/10.15288/jsad.24-00210
RethinkTHC
RethinkTHC Research Database. "Typologies of Maternal Substance Use in Pregnancy: Latent Cl..." RTHC-06748. Retrieved from https://rethinkthc.com/research/jenkins-2025-typologies-of-maternal-substance
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.